- Home
- MYSZ vs INM Comparison
MYSZ vs INM Comparison
Compare MYSZ & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYSZ
- INM
- Stock Information
- Founded
- MYSZ 1999
- INM 1981
- Country
- MYSZ Israel
- INM Canada
- Employees
- MYSZ N/A
- INM N/A
- Industry
- MYSZ Computer Software: Prepackaged Software
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- MYSZ Technology
- INM Health Care
- Exchange
- MYSZ Nasdaq
- INM Nasdaq
- Market Cap
- MYSZ 2.9M
- INM 3.2M
- IPO Year
- MYSZ N/A
- INM N/A
- Fundamental
- Price
- MYSZ $1.28
- INM $2.30
- Analyst Decision
- MYSZ Strong Buy
- INM
- Analyst Count
- MYSZ 1
- INM 0
- Target Price
- MYSZ $3.00
- INM N/A
- AVG Volume (30 Days)
- MYSZ 163.8K
- INM 46.6K
- Earning Date
- MYSZ 05-19-2025
- INM 05-13-2025
- Dividend Yield
- MYSZ N/A
- INM N/A
- EPS Growth
- MYSZ N/A
- INM N/A
- EPS
- MYSZ N/A
- INM N/A
- Revenue
- MYSZ $8,257,000.00
- INM $4,832,013.00
- Revenue This Year
- MYSZ $29.71
- INM N/A
- Revenue Next Year
- MYSZ N/A
- INM N/A
- P/E Ratio
- MYSZ N/A
- INM N/A
- Revenue Growth
- MYSZ 18.02
- INM N/A
- 52 Week Low
- MYSZ $1.01
- INM $1.72
- 52 Week High
- MYSZ $9.40
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- MYSZ 46.43
- INM 34.09
- Support Level
- MYSZ $1.21
- INM $2.70
- Resistance Level
- MYSZ $1.61
- INM $3.20
- Average True Range (ATR)
- MYSZ 0.11
- INM 0.23
- MACD
- MYSZ -0.00
- INM -0.05
- Stochastic Oscillator
- MYSZ 30.19
- INM 5.26
About MYSZ My Size Inc.
My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.